{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:52:26Z","timestamp":1792047146300,"version":"4.4.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1994,10,1]],"date-time":"1994-10-01T00:00:00Z","timestamp":780969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1994,10]]},"DOI":"10.1007\/bf02215950","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T13:43:59Z","timestamp":1128606239000},"page":"173-180","source":"Crossref","is-referenced-by-count":62,"title":["Desmopressin (DDAVP) and hemostasis"],"prefix":"10.1007","volume":"69","author":[{"given":"S.","family":"Lethagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02215950_CR1","first-page":"1250","volume":"32","author":"M Zaoral","year":"1967","unstructured":"Zaoral M, Kolc J, Sorm F (1967) Amino acids and peptides. LXXI. Synthesis of 1-deamino-8-d-amino-butyrine vasopressin, 1-deamino-8-d-lysine vasopressin and 1-deamino-8-d-arginine vasopressin. Collection Czechoslov. Chem Commun 32:1250\u20131257","journal-title":"Chem Commun"},{"key":"BF02215950_CR2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0005-2744(76)90015-2","volume":"422","author":"R Walter","year":"1976","unstructured":"Walter R (1976) Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neu-rohypophysial hormones by kidney preparations of various species. Biochim Biophys Acta 422:138\u2013158","journal-title":"Biochim Biophys Acta"},{"key":"BF02215950_CR3","first-page":"271","volume-title":"Antidiuretic hormone","author":"K Shimizu","year":"1980","unstructured":"Shimizu K, Hoshine M, Kumagawa J et al (1980) Mechanism of the prolonged antidiuretic action of DDAVP and its metabolic features. In: Share L, Yoshida S, Yagi K (eds) Antidiuretic hormone. University Park Press, Baltimore, pp 271\u2013284"},{"key":"BF02215950_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1113\/jphysiol.1961.sp006670","volume":"156","author":"GIC Ingram","year":"1961","unstructured":"Ingram GIC (1961) Increase in antihaemophilic globulin activity following infusion of adrenaline. J Physiol 156:217\u2013224","journal-title":"J Physiol"},{"key":"BF02215950_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00365516309079784","volume":"15","author":"O Egeberg","year":"1963","unstructured":"Egeberg O (1963) Changes in the activity of antihemophilic A factor (f.VIII) and in the bleeding time associated with muscular exercise and adrenaline infusion. Scand J Clin Lab Invest 15:539","journal-title":"Scand J Clin Lab Invest"},{"key":"BF02215950_CR6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.11.11.959","volume":"11","author":"S Schneck","year":"1961","unstructured":"Schneck S, von Kaulla KN (1961) Fibrinolysis and the nervous system. Neurology (Minneapolis) 11:959","journal-title":"Neurology (Minneapolis)"},{"key":"BF02215950_CR7","first-page":"105","volume-title":"Thrombosis: risk factors and diagnostic approaches","author":"PM Mannucci","year":"1972","unstructured":"Mannucci PM, Gagnatelli G, D'Alonzo R (1972) Stress and blood coagulation. In: Brinkhous KM, Hinnom S (eds) Thrombosis: risk factors and diagnostic approaches. Schattauer, Stuttgart, pp 105\u20131"},{"key":"BF02215950_CR8","first-page":"363","volume":"27","author":"JD Cash","year":"1974","unstructured":"Cash JD, Gader AMA, Da Costa J (1974) The release of plasminogen activator and factor VIII by LVP, AVP, DDAVP, AT III and OT in man. Br J Haematol 27:363\u2013364","journal-title":"Br J Haematol"},{"key":"BF02215950_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1975.tb00521.x","volume":"30","author":"PM Mannucci","year":"1975","unstructured":"Mannucci PM, \u00c5berg M, Nilsson IM, Robertsson B (1975) Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 30:81\u201393","journal-title":"Br J Haematol"},{"key":"BF02215950_CR10","first-page":"92","volume-title":"Progress in chemical fibrinolysis and thrombolysis","author":"M \u00c5berg","year":"1979","unstructured":"\u00c5berg M, Nilsson IM, Vilhardt H (1979) The release of fibrinolytic activator and factor VIII after injection of DDAVP. In: Davidsson JF (ed) Progress in chemical fibrinolysis and thrombolysis. Churchill Livingstone, Edinburgh, pp 92\u201397"},{"key":"BF02215950_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","volume":"1","author":"PM Mannucci","year":"1977","unstructured":"Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A (1977) 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's disease. Lancet 1:869\u2013872","journal-title":"Lancet"},{"key":"BF02215950_CR12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0049-3848(79)90220-2","volume":"16","author":"I Kobayashi","year":"1979","unstructured":"Kobayashi I (1979) Treatment of hemophilia A and von Willebrand's disease patients with an intranasal dripping of DDAVP. Thromb Res 16:775\u2013779","journal-title":"Thromb Res"},{"key":"BF02215950_CR13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0609.1980.tb02749.x","volume":"24","author":"IM Nilsson","year":"1980","unstructured":"Nilsson IM, Holmberg L, \u00c5berg M, Vilhardt H (1980) The release of plasminogen activator and factor VIII after injection of DDAVP in healthy volunteers and in patients with von Willebrand's disease. Scand J Haematol 24:351\u2013359","journal-title":"Scand J Haematol"},{"key":"BF02215950_CR14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.0954-6820.1982.tb01909.x","volume":"211","author":"IM Nilsson","year":"1982","unstructured":"Nilsson IM, Vilhardt H, Holmberg L, \u00c5stedt B (1982) Association between factor VIII related antigen and plasminogen activator. Acta Med Scand 211:105\u20131","journal-title":"Acta Med Scand"},{"key":"BF02215950_CR15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(77)91555-0","volume":"2","author":"PM Mannucci","year":"1977","unstructured":"Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A (1977) DDAVP in haemophilia. Lancet 2:1171\u20131172","journal-title":"Lancet"},{"key":"BF02215950_CR16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(85)92790-4","volume":"1","author":"NL Kobrinsky","year":"1985","unstructured":"Kobrinsky NL, Doyle JJ, Israels EDS et al (1985) Absent factor VIII response to synthetic vasopressin analogue in nephrogenic diabetes insipidus. Lancet 1:1293\u20131294","journal-title":"Lancet"},{"key":"BF02215950_CR17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM198804073181403","volume":"318","author":"DG Bichet","year":"1988","unstructured":"Bichet DG, Razzi M, Lonergan M et al (1988) Hemodynamic and coagulation responses to 1-desamino[8-d-arginine]vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 318:881\u2013887","journal-title":"N Engl J Med"},{"key":"BF02215950_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1210\/jcem-67-1-191","volume":"67","author":"B Brenner","year":"1988","unstructured":"Brenner B, Seligsohn U, Hochberg Z (1988) Normal response of factor VIII and von Willebrand factor to 1-deamino-8-d-arginine vasopressin in nephrogenic diabetes insipidus. J Clin Endocrin Metabol 67:191\u2013193","journal-title":"J Clin Endocrin Metabol"},{"key":"BF02215950_CR19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0022-3476(88)80417-7","volume":"113","author":"T Ohzeki","year":"1988","unstructured":"Ohzeki T, Sunaguchi M, Tsunei M, Shinzawa T, Hanaki K, Shiraki K, Shishido H (1988) Coagulation factor responsiveness in nephrogenic diabetes insipidus. J Pediatrics 113:790","journal-title":"J Pediatrics"},{"key":"BF02215950_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0303-7207(89)90138-X","volume":"64","author":"J Schwartz","year":"1989","unstructured":"Schwartz J (1989) Vasodilation associated with V2-type vasopressin activity: findings and implications. Moll Cell Endocrinol 64:133\u2013136","journal-title":"Moll Cell Endocrinol"},{"key":"BF02215950_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-4889(90)90058-L","volume":"1052","author":"S Hashemi","year":"1990","unstructured":"Hashemi S et al (1990) DDAVP-induced release of von Willebrand factor from endothelial cells in vitro; the effect of plasma and blood cells. Biochim Biophys Acta 1052:63\u201370","journal-title":"Biochim Biophys Acta"},{"key":"BF02215950_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0041-008X(90)90089-D","volume":"102","author":"RA Macia","year":"1990","unstructured":"Macia RA, Silver AC, Gabel RA, Campbell GK, Hanna N, DiMartino MJ (1990) Hypotension induced by vasopressin antagonists in rats: role of mast cell degranulation. Toxicol Appl Pharmacol 102:117\u2013127","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF02215950_CR23","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/00000542-199005000-00016","volume":"72","author":"RA Johns","year":"1990","unstructured":"Johns RA (1990) Desmopressin is a potent vasorelaxant of aorta and pulmonary artery isolated from rabbi and rat. Anesthesiology 72:858\u2013864","journal-title":"Anesthesiology"},{"key":"BF02215950_CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0272-0590(92)90060-U","volume":"18","author":"DJ Murphy","year":"1992","unstructured":"Murphy DJ, Joran ME (1992) Respiratory and cardiovascular changes associated with toxic doses of a peptide antagonist of vasopressin in the rat. Fundam Appl Toxicol 18:307\u2013313","journal-title":"Fundam Appl Toxicol"},{"key":"BF02215950_CR25","first-page":"19","volume-title":"Progress in hemostasis and thrombosis","author":"PM Mannuci","year":"1986","unstructured":"Mannuci PM (1986) Desmopressin (DDAVP) for treatment of disorders of hemostasis. In: Coller BS (ed) Progress in hemostasis and thrombosis. Grune & Stratton, Orlando, pp 19\u201345"},{"key":"BF02215950_CR26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0609.1982.tb00565.x","volume":"29","author":"IM Nilsson","year":"1982","unstructured":"Nilsson IM, Mikaelsson M, Vilhardt H (1982) The effect of intranasal DDAVP on coagulation and fibrinolytic activity in normal persons. Scand J Haematol 29:70\u201374","journal-title":"Scand J Haematol"},{"key":"BF02215950_CR27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/303530a0","volume":"303","author":"HV Stel","year":"1983","unstructured":"Stel HV, van der Kwast ThH, Veerman ECI (1983) Detection of factor VIII\/coagulant antigen in human liver-tissue. Nature 303:530\u2013532","journal-title":"Nature"},{"key":"BF02215950_CR28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/317726a0","volume":"317","author":"KL Wion","year":"1985","unstructured":"Wion KL, Kelly D, Summerfield JA, Tuddenham EGD, Lawn RM (1985) Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 317:726\u2013729","journal-title":"Nature"},{"key":"BF02215950_CR29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/317729a0","volume":"317","author":"MG Zelechowska","year":"1985","unstructured":"Zelechowska MG, van Mourik JA, Brodniewicz-Porba T (1985) Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 317:729\u2013730","journal-title":"Nature"},{"key":"BF02215950_CR30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0049-3848(74)90218-7","volume":"4","author":"MA Howard","year":"1974","unstructured":"Howard MA, Montgomery DC, Hardisty RM (1974) Factor VIII-related antigen in platelets. Thromb Res 4:617\u2013624","journal-title":"Thromb Res"},{"key":"BF02215950_CR31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.141.5.1101","volume":"141","author":"RL Nachmann","year":"1975","unstructured":"Nachmann RL, Jaffe EA (1975) Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med 141:1101\u20131103","journal-title":"J Exp Med"},{"key":"BF02215950_CR32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0038-1653446","volume":"46","author":"FM Booyse","year":"1981","unstructured":"Booyse FM, Osikowicz G, Feder S (1981) Effects of various agents on ristocetin-Willebrand factor activity in long-term cultures of von Willebrand and normal human umbilical vein endothelial cells. Thromb Haemost 46:668","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1982.tb03888.x","volume":"52","author":"EGD Tuddenham","year":"1982","unstructured":"Tuddenham EGD, Lane RS, Rotblat F et al (1982) Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. Br J Haematol 52:259\u2013267","journal-title":"Br J Haematol"},{"key":"BF02215950_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V51.2.267.267","volume":"51","author":"HJ Weiss","year":"1978","unstructured":"Weiss HJ, Baumgartner HR, Tschopp TB, Turitto VT, Cohen D (1978) Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood 51:267\u2013279","journal-title":"Blood"},{"key":"BF02215950_CR35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V64.1.229.229","volume":"64","author":"KS Sakariassen","year":"1984","unstructured":"Sakariassen KS, Cattaneo M, van den Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ (1984) DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 64:229\u2013236","journal-title":"Blood"},{"key":"BF02215950_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0609.1992.tb00906.x","volume":"49","author":"S Lethagen","year":"1992","unstructured":"Lethagen S, Nilsson IM (1992) DDAVP-induced enhancement of platelet retention. Its dependence on plateletvon Willebrand factor and the platelet receptor GPIIb\/IIIa. Eur J Haematol 49:7\u201313","journal-title":"Eur J Haematol"},{"key":"BF02215950_CR37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0038-1648407","volume":"67","author":"S Lethagen","year":"1992","unstructured":"Lethagen S, Rugarn P (1992) The effect of DDAVP and placebo on platelet function and prolonged bleeding time induced by oral acetylsalicylic acid treatment in healthy volunteers. Thromb Haemost 67:185\u2013186","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1981.tb02789.x","volume":"47","author":"PM Mannuci","year":"1981","unstructured":"Mannuci PM, Canciani MT, Rota L, Donovan BS (1981) Response of factor VIII\/von Willebrand factor to DDAVP in healthy subjects, and patients with haemophilia A and von Willebrand's disease. Br J Haematol 47:283\u2013293","journal-title":"Br J Haematol"},{"key":"BF02215950_CR39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1055\/s-0038-1646050","volume":"58","author":"S Lethagen","year":"1987","unstructured":"Lethagen S, Harris AS, Sj\u00f6rin E, Nilsson IM (1987) Intranasal and intravenous administration of desmopressin: effect on f VIII\/vWF, pharmacokinetics and reproducibility. Thromb Haemost 58:1033\u20131036","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0038-1661458","volume":"55","author":"M K\u00f6hler","year":"1986","unstructured":"K\u00f6hler M, Hellstern P, Miyashita C, von Blohm G, Wenzel E (1986) Comparative study of intranasal, subcutaneous and intravenous administration of desamino-d-arginine vasopressin (DDAVP). Thromb Haemost 55:108\u2013111","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR41","first-page":"309","volume-title":"Desmopressin in bleeding disorders","author":"M K\u00f6hler","year":"1993","unstructured":"K\u00f6hler M, Mariani G (1993) Intravenous and subcutaneous desmopressin: clinical results. In: Mariani G, Mannucci PM, Cattaneo M (eds) Desmopressin in bleeding disorders. Plenum, New York, 309\u2013316"},{"key":"BF02215950_CR42","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jps.2600751113","volume":"75","author":"AS Harris","year":"1986","unstructured":"Harris AS, Nilsson IM, Wagner ZG, Alkner U (1986) Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin. J Pharm Sci 75:1085\u20131088","journal-title":"J Pharm Sci"},{"key":"BF02215950_CR43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jps.2600770412","volume":"77","author":"AS Harris","year":"1988","unstructured":"Harris AS, Ohlin M, Lethagen S, Nilsson IM (1988) Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci 77:337\u2013339","journal-title":"J Pharm Sci"},{"key":"BF02215950_CR44","first-page":"63","volume-title":"Factor VIII\/von Willebrand factor. Biological and clinical advances","author":"IM Nilsson","year":"1986","unstructured":"Nilsson IM, Felding P, Timberg L, Jonsson S, Harris AS (1986) Clinical experience with DDAVP. In: Ciavarella NL, Ruggeri Z, Zimmerman TS (eds) Factor VIII\/von Willebrand factor. Biological and clinical advances. Proceedings of Bari Int Conference. Wichtig, Milano, pp 63\u201380"},{"key":"BF02215950_CR45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1055\/s-0038-1646051","volume":"58","author":"PM Mannucci","year":"1987","unstructured":"Mannucci PM, Vicente V, Alberca I, Sacchi E, Longo G, Harris AS, Lindquist A (1987) Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses. Thromb Haemost 58:1037\u20131039","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1055\/s-0038-1646011","volume":"58","author":"A Ghirardini","year":"1987","unstructured":"Ghirardini A, Mariani G, Iacopino G, Tirindelli MC, Solinas S, Moretti T (1987) Concentrated DDAVP: further improvement in the management of mild factor VIII deficiencies. Thromb Haemost 58:896\u2013989","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01720274","volume":"60","author":"S Lethagen","year":"1990","unstructured":"Lethagen S, Harris AS, Nilsson IM (1990) Intranasal desmopressin (DDAVP) by spray in mild haemophilia A and von Willebrand's disease type I. Blut 60:187\u2013191","journal-title":"Blut"},{"key":"BF02215950_CR48","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","volume":"66","author":"PM Mannucci","year":"1985","unstructured":"Mannucci PM, Lombardi R, Bader R et al (1985) Heterogeneity of type-I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 66:796\u2013802","journal-title":"Blood"},{"key":"BF02215950_CR49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","volume":"59","author":"ZM Ruggeri","year":"1982","unstructured":"Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS (1982) Multimeric composition of factor VIII\/ von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrands disease subtypes. Blood 59:1272\u20131278","journal-title":"Blood"},{"key":"BF02215950_CR50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","volume":"309","author":"L Holmberg","year":"1983","unstructured":"Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sj\u00f6rin E (1983) Platelet aggregation induced by 1-deamino-8-d-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease. N Engl J Med 309:816\u2013821","journal-title":"N Engl J Med"},{"key":"BF02215950_CR51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V67.2.465.465","volume":"67","author":"HR Gralnick","year":"1986","unstructured":"Gralnick HR, William SB, McKeown LP, Rick ME, Maissonneuve P, Jenneau C, Sultan Y (1986) DDAVP in type IIa von Willebrand's disease. Blood 67:465\u2013468","journal-title":"Blood"},{"key":"BF02215950_CR52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0609.1992.tb00584.x","volume":"48","author":"L Holmberg","year":"1992","unstructured":"Holmberg L, Nilsson IM (1992) Von Willebrand's disease. Eur J Haematol 48:127\u2013141","journal-title":"Eur J Haematol"},{"key":"BF02215950_CR53","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(84)91393-X","volume":"1","author":"NL Kobrinsky","year":"1984","unstructured":"Kobrinsky NL, Israels ED, Gerrard JM et al (1984) Shortening of the bleeding time by 1-deamino-8-d-arginine vasopressin in various bleeding disorders. Lancet 1:1145\u20131148","journal-title":"Lancet"},{"key":"BF02215950_CR54","first-page":"12","volume":"54","author":"G Winckelman","year":"1985","unstructured":"Winckelman G, Augustin R (1985) Improvement of primary hemostasis by DDAVP in patients with various platelet defects. Thromb Haemost 54:12","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V68.1.180.180","volume":"68","author":"GE Marti","year":"1986","unstructured":"Marti GE, Rick ME, Sidbury U, Gralnick HR (1986) DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times. Blood 68:180\u2013184","journal-title":"Blood"},{"key":"BF02215950_CR56","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1182\/blood.V67.4.1148.bloodjournal6741148","volume":"67","author":"PM Mannucci","year":"1986","unstructured":"Mannucci PM, Vicente V, Vianello L et al (1986) Controlled trial of desmopressin in liver cirrhosis and other conditions associated with prolonged bleeding time. Blood 67:1148\u20131153","journal-title":"Blood"},{"key":"BF02215950_CR57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0049-3848(87)90170-8","volume":"45","author":"S Schulman","year":"1987","unstructured":"Schulman S, Johnsson H, Egberg N, Blomb\u00e4ck M (1987) DDAVP-induced correction of prolonged bleeding time in patients with congenital platelet function defects. Thromb Res 45:165\u2013174","journal-title":"Thromb Res"},{"key":"BF02215950_CR58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajh.2830240213","volume":"24","author":"TB Kentro","year":"1987","unstructured":"Kentro TB, Lottenberg R, Kitchens CS (1987) Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgery. Am J Hematol 24:215\u2013219","journal-title":"Am J Hematol"},{"key":"BF02215950_CR59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.2830330108","volume":"33","author":"DM DiMichele","year":"1990","unstructured":"DiMichele DM, Hathaway WE (1990) Use of DDAVP in inherited and acquired platelet dysfunction. Am J Hematol 33:39\u201345","journal-title":"Am J Hematol"},{"key":"BF02215950_CR60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0038-1642758","volume":"59","author":"HC Kim","year":"1988","unstructured":"Kim HC, Salva KS, Fallot PL et al (1988) Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin. Thromb Haemost 59:221\u2013224","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR61","first-page":"443","volume-title":"Hemophilia and von Willebrand's disease in the 1990s","author":"IM Nilsson","year":"1991","unstructured":"Nilsson IM, Lethagen S (1991) Current status of DDAVP formulations and their use. In: Lusher JM, Kessler CM (eds) Hemophilia and von Willebrand's disease in the 1990s. Elsevier Science, Amsterdam, pp 443\u2013453"},{"key":"BF02215950_CR62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0038-1647492","volume":"65","author":"S Schulman","year":"1991","unstructured":"Schulman S, Johnsson H (1991) Heparin, DDAVP and the bleeding time. Thromb Haemost 65:242\u2013244","journal-title":"Thromb Haemost"},{"key":"BF02215950_CR63","first-page":"597","volume":"156","author":"S Lethagen","year":"1990","unstructured":"Lethagen S, Rugarn P, \u00c5berg M, Nilsson IM (1990) Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanisms. Acta Chir Scand 156:597\u2013602","journal-title":"Acta Chir Scand"},{"key":"BF02215950_CR64","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198012043032302","volume":"303","author":"PA Jansson","year":"1980","unstructured":"Jansson PA, Jubelirer SJ, Weinstein MS, Deykin D (1980) Treatment of bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303:1318\u20131322","journal-title":"N Engl J Med"},{"key":"BF02215950_CR65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000182801","volume":"32","author":"AJS Watson","year":"1982","unstructured":"Watson AJS, Koegh JAB (1982) Effect of 1-deamino-8-d-arginine vasopressin on the prolonged bleeding time in chronic renal failure. Nephron 32:49\u201352","journal-title":"Nephron"},{"key":"BF02215950_CR66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198301063080102","volume":"308","author":"PM Mannucci","year":"1983","unstructured":"Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS (1983) Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308:8\u201312","journal-title":"N Engl J Med"},{"key":"BF02215950_CR67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000166822","volume":"4","author":"MD Shapiro","year":"1984","unstructured":"Shapiro MD, Kelleher SP (1984) Intranasal 1-deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. Am J Neophrol 4:260\u2013261","journal-title":"Am J Neophrol"},{"key":"BF02215950_CR68","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(83)91814-7","volume":"1","author":"G Agnelli","year":"1983","unstructured":"Agnelli G, Berretini M, Cunto MD, Nenci GG (1983) Desmopressin-induced improvement of abnormal coagulation in chronic liver disease. Lancet 1:645","journal-title":"Lancet"},{"key":"BF02215950_CR69","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/bmj.291.6506.1377","volume":"291","author":"AK Burrhoughs","year":"1985","unstructured":"Burrhoughs AK, Matthews K, Quadiri M et al (1985) Desmopressin and bleeding time in patients with cirrhosis. Br Med J 291:1377\u20131381","journal-title":"Br Med J"},{"key":"BF02215950_CR70","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-114-7-563","volume":"114","author":"EH Rose","year":"1991","unstructured":"Rose EH, Aledort LM (1991) Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann Intern Med 114:563\u2013568","journal-title":"Ann Intern Med"},{"key":"BF02215950_CR71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01738476","volume":"66","author":"S Lethagen","year":"1993","unstructured":"Lethagen S, Ragnarson-Tenvall G (1993) Self-treatment with desmopressin intranasal spray in patients with bleeding disorders. Effect on bleeding symptoms and socioeconomic factors. Ann Hematol 66:257\u2013260","journal-title":"Ann Hematol"},{"key":"BF02215950_CR72","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(77)91469-6","volume":"2","author":"G Lowe","year":"1977","unstructured":"Lowe G, Pettigrew A, Middleton S, Frobes CD, Prentice CRM (1977) DDAVP in haemophilia. Lancet 2:614\u2013615","journal-title":"Lancet"},{"key":"BF02215950_CR73","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0049-3848(78)90240-2","volume":"13","author":"W Theiss","year":"1978","unstructured":"Theiss W, Schmidt G (1978) DDAVP and von Willebrand disease: repeated administration and the behaviour of the bleeding time. Thromb Res 13:1119\u20131123","journal-title":"Thromb Res"},{"key":"BF02215950_CR74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1992.tb04598.x","volume":"82","author":"PM Mannucci","year":"1992","unstructured":"Mannucci PM, Bettega D, Cattaneo M (1992) The development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol 82:87\u201393","journal-title":"Br J Haematol"},{"key":"BF02215950_CR75","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJM198605293142202","volume":"314","author":"EW Salzman","year":"1986","unstructured":"Salzman EW, Weinstein MJ, Weintraub RM et al (1986) Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 314:1402\u20131406","journal-title":"N Engl J Med"},{"key":"BF02215950_CR76","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-107-4-446","volume":"107","author":"NL Kobrinsky","year":"1987","unstructured":"Kobrinsky NL, Letts RM, Patel LR, Israels ED, Monson RC, Schweiz N, Cheang MS (1987) 1-Desamino-8-d-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double-blinded, controlled trial. Ann Intern Med 107:446\u2013450","journal-title":"Ann Intern Med"},{"key":"BF02215950_CR77","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.CIR.77.6.1319","volume":"77","author":"E Rocha","year":"1988","unstructured":"Rocha E, Llorens R, Paramo JA, Arcas R, Cuesta B, Trenor AM (1988) Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation 77:1319\u20131323","journal-title":"Circulation"},{"key":"BF02215950_CR78","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM198911233212104","volume":"321","author":"T Hackman","year":"1989","unstructured":"Hackman T, Gascoyne RD, Naiman SC et al (1989) A trial of desmopressin (1-desamino-8-d-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med 321:1437\u20131443","journal-title":"N Engl J Med"},{"issue":"Suppl IV","key":"BF02215950_CR79","first-page":"413","volume":"82","author":"WD Lazenby","year":"1990","unstructured":"Lazenby WD, Russo I, Zadeh BJ, Zelano JA, Ko W, Lynch CC, Isom OW, Krieger KH (1990) Treatment with desmo-pressin acetate in routine artery bypass surgery to improve postoperative hemostasis. Circulation 82 [Suppl IV]: 413\u2013419","journal-title":"Circulation"},{"key":"BF02215950_CR80","first-page":"165","volume":"57","author":"J Cicero Lo","year":"1991","unstructured":"Lo Cicero J, Massad M, Matano J (1991) Effect of desmopressin acetate on hemorrhage without identifiable cause in coronary bypass patients. Am Surg 57:165\u2013168","journal-title":"Am Surg"},{"key":"BF02215950_CR81","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/01.CIR.84.5.2063","volume":"84","author":"JC Horrow","year":"1991","unstructured":"Horrow JC, van Riper DF, Strong MD, Brodsky I, Parmet JL (1991) Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 84:2063\u20132070","journal-title":"Circulation"},{"key":"BF02215950_CR82","first-page":"14","volume":"37","author":"J Guay","year":"1990","unstructured":"Guay J, Reinberg C, Rivard GE, Poitras B, Mathews S, David M (1990) DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Can J Anaesth 37:14","journal-title":"Can J Anaesth"},{"key":"BF02215950_CR83","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0140-6736(93)91581-6","volume":"342","author":"M Cattaneo","year":"1993","unstructured":"Cattaneo M, Mannucci PM (1993) Desmopressin and blood loss after cardiac surgery. Lancet 342:812","journal-title":"Lancet"},{"key":"BF02215950_CR84","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0735-1097(87)80319-4","volume":"9","author":"LSC Czer","year":"1987","unstructured":"Czer LSC, Bateman TM, Gray RJ et al (1987) Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. JACC 9:1139\u20131147","journal-title":"JACC"},{"key":"BF02215950_CR85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000542-199207000-00007","volume":"77","author":"PD Mongan","year":"1992","unstructured":"Mongan PD, Hosking MP (1992) The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology 77:38\u201346","journal-title":"Anesthesiology"},{"key":"BF02215950_CR86","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0022-5223(19)34638-0","volume":"104","author":"I Gratz","year":"1992","unstructured":"Gratz I, Koehler J, Olsen D et al (1992) The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. J Thorac Cardiovasc Surg 104:1417\u20131422","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BF02215950_CR87","first-page":"1207","volume":"113","author":"DA Triplett","year":"1989","unstructured":"Triplett DA (1989) Editorial: The bleeding time: neither pariah nor panacea. Arch Pathol Lab Med 113:1207\u20131208","journal-title":"Arch Pathol Lab Med"},{"key":"BF02215950_CR88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1537-2995.1982.22382224947.x","volume":"22","author":"M Mikaelsson","year":"1982","unstructured":"Mikaelsson M, Nilsson IM, Vilhardt H, Wiechel B (1982) Factor VIII concentrate prepared from blood donors stimulated by intranasal administration of a vasopressin analogue. Transfusion 22:229\u2013233","journal-title":"Transfusion"},{"key":"BF02215950_CR89","first-page":"187","volume":"18","author":"DS Palmer","year":"1988","unstructured":"Palmer DS, Harris AS, Tittley P, Rock G (1988) Effectiveness, specificity and safety of intranasal 1-deamino-8-d-arginine vasopressin treatment of normal blood donors. Haemostasis 18:187\u2013196","journal-title":"Haemostasis"},{"key":"BF02215950_CR90","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood.V72.5.1449.1449","volume":"72","author":"PM Mannucci","year":"1988","unstructured":"Mannucci PM (1988) Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 72:1449\u20131455","journal-title":"Blood"},{"key":"BF02215950_CR91","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1651-2227.1984.tb09911.x","volume":"73","author":"O Koskimies","year":"1984","unstructured":"Koskimies O, Pylkk\u00e4nen J, Vilska J (1984) Water intoxication in infants caused by the urine concentration test with vasopressin analogue (DDAVP). Acta Paediatr Scand 73:131\u2013132","journal-title":"Acta Paediatr Scand"},{"key":"BF02215950_CR92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7326\/0003-4819-103-1-6","volume":"103","author":"B Fuente de la","year":"1985","unstructured":"de la Fuente B, Kasper CK, Rickles FR, Hoyer LW (1985) Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med 103:6\u201314","journal-title":"Ann Intern Med"},{"key":"BF02215950_CR93","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-3476(89)80575-X","volume":"114","author":"LL Sheperd","year":"1989","unstructured":"Sheperd LL, Hutchinson RJ, Worden EK, Koopman CF, Coran A (1989) Hyponatremia and seizures after intravenous administration of desmopressin acetate for surgical hemostasis. J Pediatr 114:470\u2013472","journal-title":"J Pediatr"},{"key":"BF02215950_CR94","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ajh.2830320405","volume":"32","author":"RE Weinstein","year":"1989","unstructured":"Weinstein RE, Bona RD, Altman AJ, Quinn JJ, Weisman SJ, Bartolomeo A, Rickles FR (1989) Severe hyponatremia after repeated intravenous administration of desmopressin. Am J Hematol 32:258\u2013261","journal-title":"Am J Hematol"},{"key":"BF02215950_CR95","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830310310","volume":"31","author":"TJ Smith","year":"1989","unstructured":"Smith TJ, Gill JC, Ambrosu DR, Hathaway WE (1989) Hyponatremia and seizures in young children given DDAVP. Am J Hematol 31:199\u2013202","journal-title":"Am J Hematol"},{"key":"BF02215950_CR96","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-3476(05)82685-X","volume":"116","author":"A Salvatoni","year":"1990","unstructured":"Salvatoni A, Maghnie M, Lorini R, Marni E (1990) Hyponatremia and seizures during desmopressin acetate treatment in hypothyroidism. J Pediatr 116:835\u2013836","journal-title":"J Pediatr"},{"key":"BF02215950_CR97","first-page":"3670","volume":"112","author":"LJC Binch","year":"1992","unstructured":"Binch LJC, Jacobsen MB (1992) Hyponatremia in the treatment of von Willebrand's disease (in Norwegian). Tidsskr Nor Laegeforen 112:3670\u20133671","journal-title":"Tidsskr Nor Laegeforen"},{"key":"BF02215950_CR98","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/000992289203100913","volume":"31","author":"PS Beach","year":"1992","unstructured":"Beach PS, Beach RE, Smith LR (1992) Hyponatremic seizures in a child treated with desmopressin to control enuresis. A rational approach to fluid intake. Clin Pediatr Phila 31:566\u2013569","journal-title":"Clin Pediatr Phila"},{"key":"BF02215950_CR99","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/15563659209017947","volume":"30","author":"G Yaouyanc","year":"1992","unstructured":"Yaouyanc G, Jonville AP, Yaouyanc-Lapalle H, Barbier P, Dutertre JP, Autret E (1992) Seizure with hyponatremia in a child prescribed desmopressin for nocturnal enuresis. J Toxicol Clin Toxicol 30:637\u2013641","journal-title":"J Toxicol Clin Toxicol"},{"key":"BF02215950_CR100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.2830440104","volume":"44","author":"KE Humphries","year":"1993","unstructured":"Humphries KE, Siragy H (1993) Significant hyponatremia following DDAVP administration in a healthy adult. Am J Hematol 44:12\u201315","journal-title":"Am J Hematol"},{"key":"BF02215950_CR101","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(89)92161-2","volume":"1","author":"JR O'Brien","year":"1989","unstructured":"O'Brien JR, Green PJ, Salmon G et al (1989) Desmopressin and myocardial infarction. Lancet 1:664","journal-title":"Lancet"},{"key":"BF02215950_CR102","first-page":"664","volume":"1","author":"JM Dantzig van","year":"1989","unstructured":"van Dantzig JM, Duren DR, ten Cate JW (1989) Desmopressin and myocardial infarction. Lancet 1:664","journal-title":"Lancet"},{"key":"BF02215950_CR103","first-page":"121","volume":"318","author":"L Bond","year":"1988","unstructured":"Bond L, Bevan DU (1988) Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl J Med 318:121","journal-title":"N Engl J Med"},{"key":"BF02215950_CR104","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(89)90915-X","volume":"2","author":"PM Mannucci","year":"1989","unstructured":"Mannucci PM, Lusher JM (1989) Desmopressin and thrombosis. Lancet 2:675\u2013676","journal-title":"Lancet"},{"key":"BF02215950_CR105","first-page":"154","volume":"71","author":"PM Mannucci","year":"1994","unstructured":"Mannucci PM, Carlsson S, Harris AS (1994) Desmopressin, surgery and thrombosis. Thromb Haemost 71:154\u2013155","journal-title":"Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02215950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02215950\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02215950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:14:27Z","timestamp":1586495667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02215950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,10]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994,10]]}},"alternative-id":["BF02215950"],"URL":"https:\/\/doi.org\/10.1007\/bf02215950","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,10]]}}}